Latest advice for medicines users
Drug safety advice
There is an increased risk of tuberculosis, or reactivation of latent tuberculosis, during treatment with tumour necrosis factor alpha (TNF-alpha) inhibitors. Tuberculosis in patients receiving TNF-alpha inhibitors can be life-threatening, and deaths from tuberculosis have occurred in these patients.
Yellow Card Scheme update
It is important to collect reports of suspected adverse reactions experienced by the woman or child associated with medicines taken during pregnancy. This information improves our understanding of a medicine’s effect during pregnancy and informs treatment decisions to maximise the benefit and minimise the risk to the woman and child.
Pharmacists and dispensers should take care to ensure that checking procedures are in place to reduce the risk of drug-name confusions and drug strength and quantity confusions.